Based on our results described above, which showed the suppression of TAP induced tumor promoting inflammation in IL-17R-/- mice, further experiments were to examine whether neutralization of IL-17 could inhibit inflammation associated tumor progression in mice which had already developed DMBA/TPA induced skin tumors. The gene discussed is IL17A; the disease is skin neoplasm.